BioCentury | Jan 3, 2017
Distillery Therapeutics


INDICATION: Colorectal cancer Patient sample, cell culture and mouse studies suggest soluble IL1RL1 could help treat metastatic colorectal cancer. In patient samples, low levels of IL1RL1 were associated with high microvessel density in primary tumors,...
BioCentury | Nov 5, 2015
Distillery Therapeutics

Therapeutics: S100 calcium binding protein A7 (S100A7; psoriasin)

Infectious disease INDICATION: Fungal infection Rodent studies identified a reduced form of S100A7 that could help treat fungal infections. Analysis of skin samples from psoriasis patients - whose lesions are resistant to fungal infections - identified a...
BioCentury | May 15, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...using epithelial cells that express mouse oocyte genes identified Folr4 as a surface receptor for izumo sperm-egg fusion (Izumo1)...
...infertile despite normal growth and natural mating behavior. Next steps include exploring the role of IZUMO1...
BioCentury | Sep 3, 2012
Company News

Takeda management update

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Pharmaceuticals Hired: Seigo Izumo as head of Takeda's metabolic diseases drug discovery unit WIR Staff...
BioCentury | Sep 15, 2008
Company News

Gilead management update

Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Biopharmaceuticals, Infectious, Pulmonary Hired: Seigo Izumo as SVP of cardiovascular therapeutics, formerly VP and global head of cardiovascular research at Novartis AG 's Novartis Institutes for BioMedical...
Items per page:
1 - 5 of 5